GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Medicine Man Technologies Inc (OTCPK:SHWZ) » Definitions » Piotroski F-Score

SHWZ (Medicine Man Technologies) Piotroski F-Score : 3 (As of Mar. 24, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Medicine Man Technologies Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Medicine Man Technologies has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Medicine Man Technologies's Piotroski F-Score or its related term are showing as below:

SHWZ' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 4   Max: 6
Current: 3

During the past 10 years, the highest Piotroski F-Score of Medicine Man Technologies was 6. The lowest was 1. And the median was 4.


Medicine Man Technologies Piotroski F-Score Historical Data

The historical data trend for Medicine Man Technologies's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicine Man Technologies Piotroski F-Score Chart

Medicine Man Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.00 4.00 6.00 4.00 2.00

Medicine Man Technologies Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 4.00 2.00 5.00 3.00

Competitive Comparison of Medicine Man Technologies's Piotroski F-Score

For the Pharmaceutical Retailers subindustry, Medicine Man Technologies's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicine Man Technologies's Piotroski F-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medicine Man Technologies's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Medicine Man Technologies's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun24) TTM:Last Year (Jun23) TTM:
Net Income was -0.322 + -29.365 + -16.053 + -13.937 = $-59.7 Mil.
Cash Flow from Operations was 6.946 + 3.452 + -3.7 + -0.108 = $6.6 Mil.
Revenue was 46.747 + 43.325 + 41.601 + 43.236 = $174.9 Mil.
Gross Profit was 21.438 + 7.034 + 17.934 + 19.044 = $65.5 Mil.
Average Total Assets from the begining of this year (Jun23)
to the end of this year (Jun24) was
(368.959 + 370.591 + 358.144 + 346.607 + 339.611) / 5 = $356.7824 Mil.
Total Assets at the begining of this year (Jun23) was $369.0 Mil.
Long-Term Debt & Capital Lease Obligation was $163.5 Mil.
Total Current Assets was $46.3 Mil.
Total Current Liabilities was $85.3 Mil.
Net Income was 1.809 + -27.339 + 1.745 + -6.608 = $-30.4 Mil.

Revenue was 43.191 + 40.147 + 40.001 + 42.375 = $165.7 Mil.
Gross Profit was 22.476 + 21.719 + 23.033 + 24.519 = $91.7 Mil.
Average Total Assets from the begining of last year (Jun22)
to the end of last year (Jun23) was
(318.148 + 329.581 + 322.883 + 323.39 + 368.959) / 5 = $332.5922 Mil.
Total Assets at the begining of last year (Jun22) was $318.1 Mil.
Long-Term Debt & Capital Lease Obligation was $171.0 Mil.
Total Current Assets was $66.5 Mil.
Total Current Liabilities was $49.8 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Medicine Man Technologies's current Net Income (TTM) was -59.7. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Medicine Man Technologies's current Cash Flow from Operations (TTM) was 6.6. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun23)
=-59.677/368.959
=-0.16174426

ROA (Last Year)=Net Income/Total Assets (Jun22)
=-30.393/318.148
=-0.09553101

Medicine Man Technologies's return on assets of this year was -0.16174426. Medicine Man Technologies's return on assets of last year was -0.09553101. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Medicine Man Technologies's current Net Income (TTM) was -59.7. Medicine Man Technologies's current Cash Flow from Operations (TTM) was 6.6. ==> 6.6 > -59.7 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun23 to Jun24
=163.519/356.7824
=0.45831577

Gearing (Last Year: Jun23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun22 to Jun23
=170.958/332.5922
=0.51401687

Medicine Man Technologies's gearing of this year was 0.45831577. Medicine Man Technologies's gearing of last year was 0.51401687. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jun24)=Total Current Assets/Total Current Liabilities
=46.264/85.304
=0.54234268

Current Ratio (Last Year: Jun23)=Total Current Assets/Total Current Liabilities
=66.532/49.771
=1.33676237

Medicine Man Technologies's current ratio of this year was 0.54234268. Medicine Man Technologies's current ratio of last year was 1.33676237. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Medicine Man Technologies's number of shares in issue this year was 79.073. Medicine Man Technologies's number of shares in issue last year was 60.538. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=65.45/174.909
=0.37419458

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=91.747/165.714
=0.55364664

Medicine Man Technologies's gross margin of this year was 0.37419458. Medicine Man Technologies's gross margin of last year was 0.55364664. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun23)
=174.909/368.959
=0.4740608

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun22)
=165.714/318.148
=0.52087079

Medicine Man Technologies's asset turnover of this year was 0.4740608. Medicine Man Technologies's asset turnover of last year was 0.52087079. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+0+1+1+0+0+0+0
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Medicine Man Technologies has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

Medicine Man Technologies  (OTCPK:SHWZ) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Medicine Man Technologies Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Medicine Man Technologies's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicine Man Technologies Business Description

Traded in Other Exchanges
N/A
Address
865 N. Albion Street, Suite 300, Denver, CO, USA, 80220
Medicine Man Technologies Inc is a vertically integrated multi-state cannabis operator focused on growth through expansion into existing and new markets. The Company's business involves the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis-related products. The Company sells products it manufactures and cultivates and a variety of other cannabis goods through wholly-owned retail stores, licensing arrangements, and/or third-party operators and retailers. Its operations are organized into three different segments: Retail, consisting of retail locations for sale of cannabis products; Wholesale, consisting of manufacturing, cultivation, and sale of both wholesale cannabis and non-cannabis products; and Other, consisting of all other income and expenses.
Executives
Daniel Pabon officer: General Counsel 4880 HAVANA STREET, SUITE 201, DENVER CO 80212
Christine Jones officer: Chief Legal Officer C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA ST., SUITE 201, DENVER CO 80239
Forrest Hoffmaster officer: CFO C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA ST., SUITE 201, DENVER CO 80239
Nirup Krishnamurthy director, officer: President 4880 HAVANA STREET, SUITE 201, DENVER CO 80239
Kathy P Vrabeck director 625 WESTPORT PARKWAY, GRAPEVINE TX 76051
Jeff Garwood director 55 TABBY CIRCLE, DAUFUSKIE ISLAND SC 29915
Pratap Chandra Mukharji director 4880 HAVANA STREET, SUITE 201, DENVER CO 80239
Salim Husan Wahdan director 4880 HAVANA ST., STE. 201, DENVER CO 80239
Paul Joseph Montalbano director 4880 HAVANA ST., STE. 201, DENVER CO 80239
Brad Stewart director C/O SEMPER PARATUS ACQUISITION CORP., 767 THIRD AVENUE, 38TH FLOOR, NEW YORK NY 10017
Justin Dye director, 10 percent owner, officer: CEO C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA STREET, SUITE 201, DENVER CO 80239
Jeffrey Alley Cozad director, 10 percent owner C/O MEDICINE MAN TECHNOLOGIES, INC., 4880 HAVANA ST., SUITE 201, DENVER CO 80239
Crw Capital Holdings Ii, Llc 10 percent owner 4740 W. MOCKINGBIRD LANE, STE 195579, DALLAS TX 75209
Crw Capital, Llc 10 percent owner 4740 W. MOCKINGBIRD LANE, P.O. BOX 195579, DALLAS TX 75209
Crw Capital Cann Holdings, Llc 10 percent owner 4740 W. MOCKINGBIRD LANE, P.O. BOX 195579, DALLAS TX 75209